Oncolytic Virotherapy Advances

About

Webinar Overview

As part of the Preclinical & Translational Research Series, this webinar explores recent advances in viral-based cancer therapies, focusing on oncolytic viruses, preclinical models, safety considerations, and therapeutic strategies supporting clinical translation.

Objectives

• Explain biological principles of oncolytic and viral-based cancer therapies, including tumor selectivity and viral replication mechanisms.
• Differentiation of major viral platforms and preclinical models for evaluating viral-based cancer therapies.
• Assess safety considerations and therapeutic strategies enhancing efficacy of viral-based cancer therapies.
• Interpret key preclinical findings and translational challenges influencing progression to clinical trials.